Product How it works Pricing Blog FAQ About Contact
Aurinia Pharmaceuticals

Aurinia Pharmaceuticals (NASDAQ: AUPH) revenue

Aurinia Pharmaceuticals reported revenue of $283.1m for fiscal 2025, 20.4% more than in fiscal 2024 ($235.1m). Since fiscal 2019 its revenue has grown by 88,911.0%, an average growth of 210.2% a year.

Aurinia Pharmaceuticals has grown its revenue for 4 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record. The biggest drop was in fiscal 2021, −9.0%.

Revenue, in millions of US dollars0.3201950.1202045.62021134.02022175.52023235.12024283.12025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$283.1m+20.4%$104.9m37.1%
2024$235.1m+34.0%−$4.7m−2.0%
2023$175.5m+31.0%−$91.7m−52.2%
2022$134.0m+193.9%−$111.5m−83.2%
2021$45.6m−9.0%−$180.7m−396.3%
2020$50.1m+15,660.4%−$104.3m−208.1%
2019$0.3m—−$90.9m−28,598.4%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Aurinia Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Aurinia Pharmaceuticals ranks 224th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Aurinia Pharmaceuticals, 20.4%.

RankCompanyRevenueRevenue growth
222ndRigel Pharmaceuticals$294.3m64.1%
223rdXeris Biopharma$291.8m43.7%
224thAurinia Pharmaceuticals$283.1m20.4%
225thAdaptive Biotechnologies$277.0m54.8%
226thVericel$276.3m16.5%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Aurinia Pharmaceuticals

How much revenue did Aurinia Pharmaceuticals make in fiscal 2025?
Aurinia Pharmaceuticals reported revenue of $283.1m for fiscal 2025, compared with $235.1m in fiscal 2024.
How much has the revenue of Aurinia Pharmaceuticals grown?
Between fiscal 2019 and fiscal 2025 it went from $0.3m to $283.1m: 88,911.0% more, an average growth of 210.2% a year.
What was the best year for revenue at Aurinia Pharmaceuticals?
Of its last 7 fiscal years, fiscal 2025, with $283.1m.
Where does Aurinia Pharmaceuticals rank in its sector by revenue?
It ranks 224th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Aurinia Pharmaceuticals come from?
From the annual report (Form 10-K) that Aurinia Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Aurinia Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Aurinia Pharmaceuticals: the Aurinia Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.